Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Interleukin-6 induces increased motility, cell–cell and cell–substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells

Oncogene volume 29, pages 2599–2600 (2010)Cite this article

Subjects

Two recent articles in Oncogene claim to have made the discovery that interleukin-6 (IL-6) ‘induces an epithelial–mesenchymal transition phenotype in human breast cancer cells’ (Sullivan et al., 2009) and that IL-6 ‘promotes migration and invasion of breast cancer cells’ (Walter et al., 2009). Specifically, Sullivan et al. (2009) write, ‘To our knowledge, this is the first study that shows IL-6 as an inducer of an EMT phenotype in breast cancer cells and implicates its potential to promote breast cancer metastasis.’ I write to point out that this claim is incorrect and is anticipated by work carried out between 1988 and 1995 in the laboratories of Dr Igor Tamm of The Rockefeller University (Tamm et al., 1989, 1991a, 1991b, 1994a, 1994b, 1998; Krueger et al., 1991; Sehgal and Tamm, 1991) and of Dr Michel Revel of The Weizmann Institute (Chen et al., 1988, 1991). Indeed, three of the four cell lines now investigated by Sullivan et al. (2009)—T47D, ZR-75-1 and MCF-7—were extensively investigated by Tamm and colleagues and by Revel and colleagues with the discovery, already in 1989–1994, that IL-6 induced loss of cell–cell adhesion, epithelial-to-mesenchymal transformation (also called ‘epithelioid-to-fibroblastoid transformation’) and increased motility of breast cancer cells. IL-6 inhibited, enhanced or had no effect on epithelial cell proliferation depending on cell type and subclone characteristics (Chen et al., 1988, 1991; Tamm et al., 1989, 1994b; Krueger et al., 1991).

In painstaking experiments typically extending over 9–10 days, Tamm and colleagues used time-lapse cinemicrophotography of IL-6-treated T47D and ZR-75-1 cell lines and subclones of ZR-75-1 to observe and document the epithelial-to-fibroblastoid transformation of breast cancer cells in response to IL-6. In these experiments, untreated T47D cells in insulin-supplemented medium formed flat epithelioid colonies with tightly apposed cell–cell junctions, while ZR-75-1 cells in estradiol-17β-supplemented medium formed multilayered three-dimensional epithelioid colonies. IL-6 dispersed these colonies, accompanied by ‘epithelioid to fibroblastoid’ transformation (Tamm et al., 1989, 1991a). The titles of the respective Tamm et al. articles published between 1989 and 1994 cited in the reference list below are in themselves informative. This body of work was summarized in 1991 as follows—‘In these [ZR-75-1 and T-47D] breast carcinoma cells, IL-6 elicits a major change in cell phenotype which is characterized by a fibroblastoid morphology, enhanced motility, increased cell–cell separation, and decreased adherence type junctions (desmosomes and focal adhesions). The new data identify IL-6 as a regulator of epithelial cell growth and of cell–cell association’ (Krueger et al., 1991). IL-6-treated T47D cells showed loss of vinculin, desmoplakin I/II, decreased F-actin stress fibers, perinuclear retraction of cytokeratin filaments and diminished intercellular keratin filament connections and cytokeratins (Tamm et al., 1989). Neutralizing antibodies to IL-6 inhibited the epithelioid-to-fibroblastoid transformation (Tamm et al., 1989, 1991a, 1991b). Similarly, Revel and colleagues, working with MCF-7, T47D and SK-BR-3 human breast carcinoma cells and clonal derivatives of T47D, reported that ‘IL-6 induces a morphological change with loss of epithelial characteristics and cell-cell adhesion’ (Chen et al., 1991). IL-6, but not TGF-α, TGF-β1, acidic FGF, basic FGF, EGF or IGF-I, produced this transformation when assayed under serum-containing culture conditions (Tamm et al., 1991b). The phenotypic changes elicited by IL-6 in the social behavior of breast cancer cells were distinct from the inhibitory effects of IL-6 on cell proliferation and DNA synthesis (Tamm et al., 1989, 1991b). A subclone of ZR-75-1 of which the proliferation was unaffected by IL-6 continued to exhibit the ‘cell-adhesion–disruption’ phenotype in response to IL-6 (Tamm et al., 1994b). IL-6-treated subclones of ZR-75-1 cells showed decreased E-cadherin at their surfaces that were not involved in cell–cell contacts (Tamm et al., 1994a).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  • Bromberg J, Wang TC . (2009). Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15: 17–80.

    Article  Google Scholar 

  • Chen L, Mory Y, Zilberstein A, Revel M . (1988). Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-β2 . Proc Natl Acad Sci USA 85: 8037–8041.

    Article  CAS  PubMed  Google Scholar 

  • Chen L, Shulman LM, Revel M . (1991). IL-6 receptors and sensitivity to growth inhibition by IL-6 in clones of human breast carcinoma cells. J Biol Regul Homeostat Agents 5: 125–136.

    CAS  Google Scholar 

  • Chiu JJ, Sgagias MK, Cowan KH . (1996). Interleukin 6 acts as a paracrine growth factor in human mammary carcinoma cell lines. Clin Cancer Res 2: 215–221.

    CAS  PubMed  Google Scholar 

  • Choppin PW . (2007). A Biographical Memoir of Igor Tamm (1922-1995). National Academy of Sciences USA: Washington, DC, pp 1–17.

    Google Scholar 

  • Krueger J, Ray A, Tamm I, Sehgal PB . (1991). Expression and function of interleukin-6 in epithelial cells. J Cell Biochem 45: 327–334.

    Article  CAS  PubMed  Google Scholar 

  • Margulies L, Sehgal PB . (1993). Modulation of the human interleukin-6 promoter (IL-6) and transcription factor C/EBPβ (NF-IL6) activity by p53 species. J Biol Chem 268: 15096–15100.

    CAS  PubMed  Google Scholar 

  • Sehgal PB . (1990). Interleukin 6 in infection and cancer. Proc Soc Exp Biol Med 195: 183–191.

    Article  CAS  PubMed  Google Scholar 

  • Sehgal PB . (1998). Cytokines in the host-tumor interaction. In: Mackiewicz A, Sehgal PB (eds). Molecular Aspects of Cancer and Its Therapy. Birkhauser Verlag: Basel, pp 89–106.

    Chapter  Google Scholar 

  • Sehgal PB, Tamm I . (1991). Interleukin-6 enhances motility of breast carcinoma cells. In: Goldberg ID (ed). Cell Motility Factors. Birkhauser Verlag: Basel–Boston–Berlin, pp 178–193.

    Chapter  Google Scholar 

  • Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N et al. (2009). Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 28: 2940–2947.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tabibzadeh SS, Poubouridis D, May LT, Sehgal PB . (1989). Interleukin-6 immunoreactivity in human tumors. Am J Pathol 135: 427–433.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tamm I, Cardinale I, Krueger J, Murphy JS, May LT, Sehgal PB . (1989). Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med 170: 1649–1669.

    Article  CAS  PubMed  Google Scholar 

  • Tamm I, Cardinale I, Murphy JS . (1991a). Decreased adherence of interleukin 6-treated breast carcinoma cells can lead to separation from neighbors after mitosis. Proc Natl Acad Sci USA 88: 4414–4418.

    Article  CAS  PubMed  Google Scholar 

  • Tamm I, Cardinale I, Sehgal PB . (1991b). Interleukin-6 and 12-O-tetradecanoyl phorbol-13-acetate act synergistically in inducing cell-cell separation and migration of human breast carcinoma cells. Cytokine 3: 212–223.

    Article  CAS  PubMed  Google Scholar 

  • Tamm I, Cardinale I, Kikuchi T, Krueger JG . (1994a). E-cadherin distribution in interleukin-6-induced cell-cell separation of ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 4338–4342.

    Article  CAS  PubMed  Google Scholar 

  • Tamm I, Kikuchi T, Cardinale I, Krueger JG . (1994b). Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 3329–3333.

    Article  CAS  PubMed  Google Scholar 

  • Tamm I, Kikuchi T, Cardinale I, Murphy JS, Krueger JG . (1998). Cytokines in breast cancer cell dyshesion. In: Mackiewicz A, Sehgal PB (eds). Molecular Aspects of Cancer and Its Therapy. Birkhauser Verlag: Basel, pp 89–106.

    Google Scholar 

  • Walter M, Liang S, Ghosh S, Hornsby PJ, Li R . (2009). Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene 28: 2745–2755.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Cell Biology & Anatomy, and Medicine, New York Medical College, Valhalla, NY, USA

    P B Sehgal

Authors
  1. P B Sehgal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P B Sehgal.

Ethics declarations

Competing interests

Dr Sehgal's work has been funded by the NIH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sehgal, P. Interleukin-6 induces increased motility, cell–cell and cell–substrate dyshesion and epithelial-to-mesenchymal transformation in breast cancer cells. Oncogene 29, 2599–2600 (2010). https://doi.org/10.1038/onc.2010.4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.4

This article is cited by

Search

Advanced search

Quick links